Search - tctmd.com

Displaying 41 - 60 of 72

Sort: Relevancy | Date

Presentation THT 2025

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Presenter: Dor Lotan

February 12, 2025

Presentation THT 2025

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 12, 2025

Presentation THT 2025

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

Presenter: Kay Everett

February 12, 2025

Presentation THT 2025

Thrombectomy: Case in a Box

Presenter: Sanjum Sethi

February 12, 2025

Presentation THT 2025

Role of MCS in PE Management

Presenter: Karthikeyan Ranganathan

February 12, 2025

Presentation THT 2025

Medical Management (Heparin/ Lytics)

Presenter: Gregory Piazza

February 12, 2025

Presentation THT 2025

Invasive Therapies (Inari/EKOS)

Presenter: Sareena George

February 12, 2025

Presentation THT 2025

Clinical Trial Updates: What's New? What's Coming?

Presenter: Jay Giri

February 12, 2025

Presentation THT 2025

Case Resolution and Discussion

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Case Presentation: Submassive PE With Normotensive Shock

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presenter: Eric Secemsky

February 12, 2025

Presentation THT 2025

Patients With Heart Failure Implanted With a Pulmonary Artery Pressure Sensor: Hemodynamic and Clinical Outcomes From the HF2 Registry

Presenter: Timothy Jordan

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Advertisement

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Acute Hemodynamic Effects of VA-ECMO on Arterial Afterload in a Preclinical Model of Normal Left Ventricular Function After Exposure to Vasodilators

Thrombectomy: Case in a Box

Role of MCS in PE Management

Medical Management (Heparin/ Lytics)

Invasive Therapies (Inari/EKOS)

Clinical Trial Updates: What's New? What's Coming?

Case Resolution and Discussion

Case Presentation: Submassive PE With Normotensive Shock

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Patients With Heart Failure Implanted With a Pulmonary Artery Pressure Sensor: Hemodynamic and Clinical Outcomes From the HF2 Registry

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content